SAN DIEGO, June 12, 2020 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX) today announced that its commercialization partner, Alvogen, has launched Teriparatide Injection in the United States.
July 24, 2009 — The US Food and Drug Administration (FDA) has approved an expanded indication for teriparatide (rDNA origin) injection (Forteo, Eli Lilly and Company, Inc) for the treatment of ...
In December 2025, Amphastar Pharmaceuticals announced that the FDA approved its abbreviated new drug application for a teriparatide injection prefilled pen, deemed bioequivalent and therapeutically ...
WESTON, Fla., Nov. 21, 2023 /PRNewswire/ - Apotex Corp. announced today the launch of Teriparatide Injection, a single-patient-use pre-filled pen used for the treatment of osteoporosis in the United ...
RANCHO CUCAMONGA, CA / ACCESS Newswire / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's ...
The use of teriparatide injections at least 1 month prior to surgery effectively increased the insertional torque of pedicle screws during fusion surgery among postmenopausal women with osteoporosis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback